Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rangering i aksjer #40984
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aksjekurs
$0.14967717
Markedsverdi
$57.63K
Endring (1 dag)
10.00%
Endring (1 år)
4.98%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategori

EPS for CRISM Therapeutics Corporation (CRTX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til CRISM Therapeutics Corporation er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for CRISM Therapeutics Corporation fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter